The Vital Role of PET/CT in NF1 Cancer Surveillance

This research study evaluates the effectiveness of 18F-FDG PET/CT scans as a proactive tool for detecting hidden cancers in adults with Neurofibromatosis type 1 (NF1). While patients with this genetic disorder are highly susceptible to both benign and malignant tumors, traditional monitoring often struggles to identify aggressive transformations in early, asymptomatic stages. By reviewing a cohort of 79 patients, the authors discovered that PET/CT imaging successfully uncovered twelve incidental malignancies, including gastrointestinal and thyroid tumors, which had been missed by other methods. These findings suggest that incorporating metabolic imaging into standard surveillance protocols can facilitate earlier surgical interventions and improve long-term survival rates. The study concludes that the benefits of early cancer detection through this modality often outweigh the concerns regarding radiation exposure in adult populations. Consequently, the authors advocate for an individualized, multidisciplinary approach that utilizes PET/CT to enhance the management of NF1-related complications.